Lag in U.S. recall highlights strains in global pharmaceutical supply chain.

A Chinese-made heart drug taken by millions of people was contaminated with a possible cancer-causing chemical.

The Food and Drug Administration oversaw a recall of the tainted pills. But even as it did so, the agency that helps safeguard a global supply chain of drugs was conducting fewer inspections of pharmaceutical plants in the country where the problem originated.

Source: Chinese Heart Drug Valsartan Recall Shows FDA Inspection Limits - Bloomberg